Amgen Set to Report Q4 Earnings: Is a Beat in the Cards? [Yahoo! Finance]

Amgen Inc. (AMGN)
Last amgen inc. earnings: 4/30 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.amgen.com
Company Research
Source: Yahoo! Finance
In This Article AMGN We expect Amgen AMGN to beat expectations when it reports fourth-quarter and full-year 2024 results on Feb. 4, after market close. In the last reported quarter, the company beat earnings expectations by 9.20%. The Zacks Consensus Estimate for fourth-quarter sales and earnings is pegged at $8.84 billion and $5.01 per share, respectively. Find the latest EPS estimates and surprises on Zacks Earnings Calendar Factors to Consider for Amgen Amgen's product sales are expected to have been driven by strong volume growth of products like Evenity, Repatha, Prolia, Kyprolis and Blincyto, among others. However, prices of most products are expected to continue to decline due to higher rebates to support expanded access. The Zac
Read more
Impact Snapshot
Event Time:
AMGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AMGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AMGN alerts
High impacting Amgen Inc. news events
Weekly update
A roundup of the hottest topics
AMGN
News
- Myris Therapeutics is Developing Ultra-High DAR ADCs to Enable Novel Precision Medicine Treatments for Cancer [Yahoo! Finance]Yahoo! Finance
- Celltrion Expands Biosimilar Portfolio in the European Union Following European Commission Approval of Two Biosimilars [Yahoo! Finance]Yahoo! Finance
- GeminiBio Appoints Mike Stella to Board [Yahoo! Finance]Yahoo! Finance
- FELDAN THERAPEUTICS ACCELERATES GROWTH WITH STRATEGIC INVESTMENT FROM LINEARIS VENTURES [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Improve Your Retirement Income with These 3 Top-Ranked Dividend Stocks [Yahoo! Finance]Yahoo! Finance
AMGN
Earnings
- 2/4/25 - Beat
AMGN
Sec Filings
- 2/19/25 - Form 144
- 2/19/25 - Form 144
- 2/19/25 - Form 144
- AMGN's page on the SEC website